Atlas Trials

A Study in Healthy Male Subjects to Understand How Savolitinib Behaves Inside the Body (Pharmacokinetics) When Administered Alone and in Combination With Famotidine

Clinical trial NCT04179071 · COMPLETED

Trial details

NCT number
NCT04179071
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumours
Start date
2019-12-13
Primary completion
2020-03-11
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.